0001209191-23-032996.txt : 20230530 0001209191-23-032996.hdr.sgml : 20230530 20230530182420 ACCESSION NUMBER: 0001209191-23-032996 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230530 FILED AS OF DATE: 20230530 DATE AS OF CHANGE: 20230530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacot Stanley Jr CENTRAL INDEX KEY: 0001909085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37383 FILM NUMBER: 23978284 MAIL ADDRESS: STREET 1: 202 COUSTEAU PLACE STE 105 CITY: DAVIS STATE: CA ZIP: 95618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcadia Biosciences, Inc. CENTRAL INDEX KEY: 0001469443 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 810571538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 202 COUSTEAU PLACE STREET 2: SUITE 105 CITY: DAVIS STATE: X1 ZIP: 95618 BUSINESS PHONE: 530-756-7077 MAIL ADDRESS: STREET 1: 202 COUSTEAU PLACE STREET 2: SUITE 105 CITY: DAVIS STATE: CA ZIP: 95618 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-30 0 0001469443 Arcadia Biosciences, Inc. RKDA 0001909085 Jacot Stanley Jr C/O ARCADIA BIOSCIENCES, INC. 5950 SHERRY LANE, SUITE 215 DALLAS TX 75225 0 1 0 0 Chief Executive Officer 0 Common stock 2023-05-30 4 P 0 5000 4.31 A 5000 D This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Stanley E. Jacot, Jr., by Attorney-in-fact, Thomas J. Schaefer 2023-05-30